We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$226M
AUM Growth
+$17.5M
Cap. Flow
+$40.7M
Cap. Flow %
18.02%
Top 10 Hldgs %
65.12%
Holding
40
New
13
Increased
11
Reduced
3
Closed
13

Top Buys

Rank Stock Value
1
VNDA icon
Vanda Pharmaceuticals
VNDA
+$17.6M
2
AVTA
Avantax, Inc. Common Stock
AVTA
+$10.8M
3
APOL
Apollo Education Group Inc Class A
APOL
+$10.6M
4
TBPH icon
Theravance Biopharma
TBPH
+$9.39M
5
LL
LL Flooring Holdings, Inc.
LL
+$9.21M

Top Sells

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$12.9M
2
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
+$10.4M
3
SODA
SodaStream International Ltd
SODA
+$8.65M
4
AEGR
Aegerion Pharmaceuticals
AEGR
+$7.79M
5
TIME
Time Inc.
TIME
+$7.63M

Sector Composition

Rank Sector Weight
1 Healthcare 45.6%
2 Consumer Discretionary 8.38%
3 Industrials 8.03%
4 Technology 6.31%
5 Financials 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRG
26
DELISTED
Ignite Restaurant Group, Inc.
IRG
$1.16M 0.52%
+240,000
New +$1.64M
NERV icon
27
Minerva Neurosciences
NERV
$191M
$1.01M 0.45%
+25,329
New +$1.05M
DRRX
28
DELISTED
DURECT Corp
DRRX
– –
-384,927
Closed -$3.04M
TVTX icon
29
Travere Therapeutics
TVTX
$5.17B
– –
-34,874
Closed -$427K
URBN icon
30
Urban Outfitters
URBN
$6.46B
– –
-172,000
Closed -$6.04M
BSTC
31
DELISTED
BioSpecifics Technologies Corp.
BSTC
– –
-105,000
Closed -$4.05M
SODA
32
DELISTED
SodaStream International Ltd
SODA
– –
-430,000
Closed -$8.65M
KND
33
DELISTED
Kindred Healthcare
KND
– –
-234,000
Closed -$4.25M
TIME
34
DELISTED
Time Inc.
TIME
– –
-310,000
Closed -$7.63M
UNXL
35
DELISTED
Uni-Pixel, Inc.
UNXL
– –
-176,000
Closed -$1M
AEGR
36
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-372,000
Closed -$7.79M
UNTD
37
DELISTED
UNITED ONLINE INC COM NEW
UNTD
– –
-350,000
Closed -$5.09M
LF
38
DELISTED
LEAPFROG ENTERPRISES INC.
LF
– –
-1,500,000
Closed -$7.08M
ZGNX
39
DELISTED
Zogenix, Inc.
ZGNX
– –
-1,175,000
Closed -$12.9M
HPTX
40
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
– –
-434,000
Closed -$10.4M
1
2

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Armistice Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Armistice Capital held 40 positions worth $226M, up 8.4% from $208M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Armistice Capital deployed $40.7M of net new capital in Q1 2015, opening 13 new positions and adding to 11 existing holdings. Its largest new stake was Avantax, Inc. Common Stock: 774,000 shares worth $10.6M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was RAPTOR PHARMACEUTICAL CORP COM STK (DE), an estimated $6.84M trimmed.

  • Armistice Capital's largest Q1 2015 buy was Avantax, Inc. Common Stock: 774,000 shares worth $10.6M.
  • Armistice Capital added most to Vanda Pharmaceuticals in Q1 2015, an estimated $17.6M increase.
  • Armistice Capital's biggest Q1 2015 reduction was RAPTOR PHARMACEUTICAL CORP COM STK (DE), cutting an estimated $6.84M.
  • Armistice Capital fully exited Zogenix, Inc. in Q1 2015, selling an estimated $12.9M.
  • Armistice Capital's ten largest holdings make up 65% of its $226M portfolio in Q1 2015.
  • Armistice Capital opened 13 new positions and closed 13 in Q1 2015.
  • Armistice Capital's portfolio value rose 8.4% quarter-over-quarter to $226M.

Based on Armistice Capital's 13F filing for Q1 2015, filed 15 May 2015.